Endoscopy AI is becoming the new standard in public healthcare.

Ainex Corporation has successfully deployed its AI-powered endoscopy diagnostic solution, ENAD, across 4 major public hospitals in South Korea — through the Public Procurement of Innovative Products.

▲ VHS Incheon Hospital
▲ Seoul SeoNam Hospital
▲ Armed Forces Capital Hospital
▲ Korea Army Seoul District Hospital

Having already reached 150+ private hospitals, ENAD has now expanded into veterans, municipal, and military hospitals — establishing a multi-layered public healthcare footprint that marks a pivotal milestone in the medical AI landscape.

ENAD is an AI Software as a Medical Device (SaMD) that detects and diagnoses lesions in real time during endoscopic procedures. It holds Korea's first comprehensive MFDS approval covering both gastric and colorectal endoscopy. Notably, ENAD CADx, an AI solution for colonoscopy diagnosis, became the first in the endoscopy AI field to pass the integrated review for innovative medical devices, marking its entry into the reimbursement process.

With successful exports to Singapore, Vietnam, and Malaysia, a growing presence in Europe, an R&D partnership with Australia, and a strategic alliance with Olympus Korea — Ainex is driving the global expansion of endoscopy AI.

"We will continue to raise the standard of endoscopy through AI and contribute to the early detection and prevention of gastrointestinal cancers."
— David Lee, CEO, Ainex Corporation